Press Releases Elevation Oncology, Inc.

Equities

ELEV

US28623U1016

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-03 EDT			5-day change	1st Jan Change
3.7 ^USD	-3.14%		+2.21%	+589.01%

05-02	Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-05	Elevation Oncology, Inc. Announces Management Changes	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements	05-03	AQ
Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements	03-07	AQ
Elevation Oncology to Participate in Upcoming Investor Conferences	02-29	AQ
Kaskela Law LLC Announces Shareholder Investigation of Elevation Oncology (ELEV) and Encourages Investors to Contact the Firm	02-29	PR
Merrimack Reports Ipsen Announcement of Approval by The US FDA of Onivyde Plus 5 Fluorouracil/Leucovorin and Oxaliplatin as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma	02-14	AQ
Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors	01-23	AQ
Latest Buzz on The Street: Noteworthy Developments at DYAI, ELEV, ATRA, ESPR, KAVL	01-17	AQ
Elevation Oncology to Present at the Piper Sandler 35th Annual Healthcare Conference	11-23	AQ
Elevation Oncology Reports Third Quarter 2023 Financial Results and Highlights Recent Business Achievements	11-03	AQ
Elevation Oncology to Present at the H.C. Wainwright 25th Annual Global Investment Conference	23-09-06	AQ
Elevation Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Business Achievements	23-08-04	AQ
Elevation Oncology Appoints Joseph Ferra as Chief Executive Officer and Promotes Tammy Furlong to Chief Financial Officer	23-07-14	AQ
Elevation Oncology Announces Pricing of $50 Million Public Offering	23-06-08	PR
Elevation Oncology Announces Launch of Proposed Public Offering	23-06-08	PR
Elevation Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Business Achievements	23-05-16	AQ
ELEVATION ONCOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-15	AQ
ELEVATION ONCOLOGY, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	23-04-17	AQ
Elevation Oncology Reports Fourth Quarter and Full Year 2022 Financial Results	23-03-09	PR
ELEVATION ONCOLOGY, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-03-09	AQ
ELEVATION ONCOLOGY, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23-03-03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Elevation Oncology, Inc.

Equities

ELEV

US28623U1016

Press Releases

Filters